Release Date: 26/09/14 11:34 Summary: Variation of Takeover Bid Price Sensitive: Yes Download Document 147.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%